CRISPR/Cas12a-based fluorescence immunoassay: combination of efficient signal generation with specific molecule recognition.
Journal
The Analyst
ISSN: 1364-5528
Titre abrégé: Analyst
Pays: England
ID NLM: 0372652
Informations de publication
Date de publication:
22 Aug 2022
22 Aug 2022
Historique:
pubmed:
4
8
2022
medline:
24
8
2022
entrez:
3
8
2022
Statut:
epublish
Résumé
Using the DNA activator of Cas to label the secondary antibody of traditional ELISA, the CRISPR/Cas12a-based fluorescence immunoassay was presented. The sensing strategy ingeniously combines the efficient signal generation of the CRISPR/Cas12a system with antigen-antibody-specific recognition. This work provides an alternative strategy to expand the application of the CRISPR/Cas system for the detection of non-nucleic acid targets.
Substances chimiques
DNA
9007-49-2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM